Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent

Abstract

 Early cross-sex hormonal interventions (that is, between 16 and 18) as a treatment for young transsexuals are often considered to be risky. However, the delay of such treatment until after the development of secondary sex characteristics has obvious drawbacks for transsexual individuals. This paper reports a postoperative follow-up case-study of a female-to-male transsexual who was treated with a combination of an LHRH agonist (which delayed her secondary sex characteristics development) and psychotherapy at age 13, and subsequently underwent sex reassignment at 18.

This is a preview of subscription content, log in to check access.

Author information

Affiliations

Authors

Additional information

Accepted: 8 June 1998

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cohen-Kettenis, P., van Goozen, S. Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent. European Child & Adolescent Psychiatry 7, 246–248 (1998). https://doi.org/10.1007/s007870050073

Download citation

  • Key words Gender identity disorder
  • transsexualism
  • adolescence
  • sex reassignment
  • hormone treatment